Carlos Campoy
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | CytomX Therapeutics, Inc. (CTMX) | Former Senior Vice President and Chief Financial Officer | $349,479 | $1,420,271 |
| 2021 | CytomX Therapeutics, Inc. (CTMX) | Former Senior Vice President and Chief Financial Officer | $477,555 | $1,396,204 |
| 2020 | CytomX Therapeutics, Inc. (CTMX) | Senior Vice President, Chief Financial Officer | $360,052 | $1,741,639 |
| 2019 | CytomX Therapeutics, Inc. (CTMX) | Senior Vice President, Chief Financial Officer | — | — |
| 2018 | CytomX Therapeutics, Inc. (CTMX) | Senior Vice President, Chief Financial Officer | — | — |
Executive changes
Earnings-call appearances
-
CytomX Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-04
CytomX Therapeutics, Inc. (CTMX)
-
CytomX Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-05
CytomX Therapeutics, Inc. (CTMX)
-
CytomX Therapeutics, Inc. Q3 FY2021 Earnings Call2021-11-04
CytomX Therapeutics, Inc. (CTMX)
-
CytomX Therapeutics, Inc. Q2 FY2021 Earnings Call2021-08-05
CytomX Therapeutics, Inc. (CTMX)
-
CytomX Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-06
CytomX Therapeutics, Inc. (CTMX)
-
CytomX Therapeutics, Inc. Q4 FY2020 Earnings Call2021-01-19
CytomX Therapeutics, Inc. (CTMX)
-
CytomX Therapeutics, Inc. Q3 FY2020 Earnings Call2020-11-05
CytomX Therapeutics, Inc. (CTMX)
-
CytomX Therapeutics, Inc. Q2 FY2020 Earnings Call2020-08-06
CytomX Therapeutics, Inc. (CTMX)
-
CytomX Therapeutics, Inc. Q1 FY2020 Earnings Call2020-05-07
CytomX Therapeutics, Inc. (CTMX)